THE MAO INHIBITORS PHENELZINE AND CLORGYLINE REVERT ENZALUTAMIDE RESISTANCE IN CASTRATION RESISTANT PROSTATE CANCER

被引：0
|
作者：
Wang, Keliang
Fang, Ruizhe
Luo, Jie
You, Bosen
Yeh, Shuyuan
Joseph, Jean V.
Messing, Edward M.
Chang, Chawnshang
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP33-05
引用
收藏
页码：E607 / E608
页数：2
相关论文
共 50 条
  • [41] Castration-Resistant Prostate Cancer: Enzalutamide better than Placebo
    Lorenz, Judith
    Kretschmer, Alexander
    AKTUELLE UROLOGIE, 2019, 50 (01) : 12 - 13
  • [42] Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
    El-Amm, Joelle
    Patel, Nihar
    Freeman, Ashley
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 235 - 245
  • [43] Re: Enzalutamide and Survival in Nonmetastatic Castration-Resistant Prostate Cancer
    Mori, Keiichiro
    Egawa, Shin
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2021, 79 (03) : 430 - 431
  • [44] Enzalutamide - a new agent for treatment of castration-resistant prostate cancer
    Wysocki, Piotr J.
    ONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (05): : 186 - 190
  • [45] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [46] COMBINATION OF INDOMETHACIN AND ENZALUTAMIDE TO TREAT CASTRATION-RESISTANT PROSTATE CANCER
    Liu, Chengfei
    Lou, Wei
    Pan, Chong-xian
    Lara, Primo
    Evans, Christopher
    Parikh, Mamta
    White, Ralph deVere
    Dall'Era, Marc
    Gao, Allen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E694 - E694
  • [47] Re: Enzalutamide in Men with Nonmetastatic, Castration-resistant Prostate Cancer
    Mason, Malcolm
    EUROPEAN UROLOGY, 2018, 74 (06) : 845 - 845
  • [48] Budget Impact of Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer
    Schultz, Neil M.
    O'Day, Ken
    Sugarman, Rebecca
    Ramaswamy, Krishnan
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (04): : 538 - 549
  • [49] Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
    Baciarello, Giulia
    Sternberg, Cora N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 14 - 24
  • [50] Integrative genomic analysis to identify emergent enzalutamide resistance mechanisms in castration-resistant prostate cancer
    Woodward, Josha
    King, Carly
    Coleman, Daniel
    Lisac, Robert
    Schwartzman, Jacob
    Wang, Nicholas
    Gleave, Martin
    Gray, Joe
    Thomas, George
    Beer, Tomasz M.
    Van Hook, Katy
    Baertsch, Robert
    Goldstein, Ted
    Stuart, Josh
    Gao, Lina
    Urrutia, Joshua
    Heiser, Laura
    Alumkal, Joshi J.
    CANCER RESEARCH, 2015, 75
12345